Standard BioTools Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Standard BioTools Inc. is a life sciences tools company that develops and commercializes precision genomic and proteomic solutions for biomedical research. The company provides instrumentation, consumables, assays, software, and services used to study genes, proteins, cellular behavior, and tissue architecture across early discovery, translational, and clinical research workflows. Its product portfolio includes platforms for genomics, single-cell analysis, spatial biology, mass cytometry, and microfluidics, supporting applications in areas such as oncology, immunology, and biomarker discovery. Standard BioTools serves academic institutions, government laboratories, pharmaceutical companies, biotechnology firms, and clinical research organizations worldwide. The company focuses on helping researchers generate high-quality, reproducible biological data that can improve understanding of health and disease.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Dr. Michael Egholm Ph.D.
- Employees
- 385
- Headquarters
- Boston, MA, United States
- Website
- www.standardbio.com